EDIT:NASDAQ
Editas Medicine Inc
2,40 US$
0,00%
(0,00) 1K
26-okt, 11:04:42 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,39 US$
Yuqori
2,44 US$
Past
2,36 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,88 mln
Hajmi
362,52 ming
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Ochish
2,39 US$
Yuqori
2,44 US$
Past
2,36 US$
Bozor kapitali
368,59 mln
Oʻrtacha hajm
2,88 mln
Hajmi
362,52 ming
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,74 US$
Beta
2,00
Muomaladagi aksiyalar
153,58 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
巴士的報
·
24 daqiqa oldin
NYSE Publishes 'The Busiest Room on Wall Street': NYSE Content Update
Seeking Alpha
·
4 daqiqa oldin
Nasdaq Soars Following Earnings Release (NASDAQ:NDAQ)
Investing.com Nigeria
·
3 daqiqa oldin
Dow Jones pulls back to MA cluster near 52,400: Live levels
SEC.gov
·
1 soat oldin
Anthropic, PBC - S-1 (Q2)
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida